How should a delayed rash after administration of equine rabies immunoglobulin (ERIG) be managed?

Management of Delayed Rash After Equine Rabies Immunoglobulin (ERIG)

Continue rabies post-exposure prophylaxis without interruption and treat the delayed rash symptomatically with antihistamines and, if needed, a short course of corticosteroids. The rash represents a serum sickness-like reaction that is self-limited and does not justify discontinuing life-saving rabies prophylaxis, as rabies is uniformly fatal once symptomatic 1.

Understanding the Delayed Rash

Delayed rashes after ERIG typically represent serum sickness-like reactions that occur 5-14 days after administration:

• The incidence of adverse reactions after purified ERIG is low (0.8%-6.0%), with most reactions being minor 1
• Serum sickness-like reactions occur in approximately 1.6%-3.6% of ERIG recipients 2, 3
• These reactions typically manifest on days 5-8 after ERIG administration, beginning at the wound site and spreading to become generalized 4, 5
• Common features include urticarial or maculopapular rashes, low-grade fever, arthralgias, and malaise 4, 6, 2

Critical Management Principle

Rabies prophylaxis must never be interrupted or discontinued because of local or mild systemic adverse reactions:

• Once initiated, rabies prophylaxis should not be interrupted due to adverse reactions 1
• The patient's risk of acquiring rabies must be carefully considered before any decision to discontinue vaccination, as rabies is nearly 100% fatal once symptomatic 1
• No deaths have been reported from serum sickness-like reactions to ERIG, and these reactions are not life-threatening 1, 2, 3

Specific Treatment Algorithm

For mild to moderate delayed rashes (the vast majority of cases):

• Administer oral antihistamines (such as levocetrizine or diphenhydramine) for symptomatic relief 4, 5
• Add anti-inflammatory agents such as ibuprofen or acetaminophen for fever and arthralgias 1
• Continue the full rabies vaccine series on schedule (days 0,3,7,14, and 28) 7
• Most reactions resolve within 5-7 days without complications 4, 5, 2

For severe or progressive reactions:

• Administer a short course (typically 5-7 days) of oral or injectable corticosteroids (such as prednisolone) 4, 6, 2
• Only approximately 15% of patients with serum sickness-like reactions require steroid therapy 3
• Hospitalization is rarely needed and was required in only 1 patient out of 419 in a large Thai study 2
• Continue rabies vaccination throughout steroid treatment 4, 6

Warning Signs Requiring Immediate Evaluation

Watch for these rare but serious complications that require urgent assessment:

• Signs of anaphylaxis (though exceedingly rare with purified ERIG): difficulty breathing, facial/lip swelling, hypotension 1
• Progressive neurologic symptoms (not typical of serum sickness) 1
• Severe systemic symptoms that worsen despite treatment 1

Key Clinical Pearls

Important considerations for optimal management:

• Children under 10 years have an extremely low risk of serum sickness (0.086%) compared to adults 3
• Females and patients over 21 years have higher rates of serum sickness-like reactions 3
• The reaction is immunologically mediated (Type III hypersensitivity) and self-limited 4, 6
• Unpurified equine antirabies serum (still used in some countries where ERIG is unavailable) has much higher rates of serious adverse reactions including anaphylaxis, but purified ERIG is significantly safer 1

Common Pitfalls to Avoid

Critical errors that compromise patient safety:

• Never discontinue the rabies vaccine series due to a delayed rash, as this places the patient at risk for a uniformly fatal disease 1
• Do not confuse serum sickness-like reactions (delayed, 5-14 days) with immediate hypersensitivity reactions (within minutes to hours) 2, 3
• Do not administer additional ERIG after day 7, as vaccine-induced antibodies are presumed to have developed and additional passive antibody could suppress the active immune response 7
• Ensure the patient completes all scheduled vaccine doses even if the rash has resolved 1

Documentation and Reporting

For quality improvement and surveillance:

• Document the temporal relationship between ERIG administration and rash onset 4
• Report serious systemic, anaphylactic, or unusual reactions to the Vaccine Adverse Event Reporting System (VAERS) 1
• Consult state or local health departments for assistance with management of serious adverse reactions 1